GALECTIN THERAPEUTICS INC reports

Company location: Norcross, GA
Fiscal year end: 31 December

GALECTIN THERAPEUTICS INC has filed 1,568 SEC EDGAR filings since 13 Jun 2001

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 101-125 of 1,000 matching filings.

Per page

25

Current page

5

8-K File 001-31791

8-K

Filing date: 16 Jun 2025
Reporting date: 16 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 11 Jun 2025
Reporting date: 03 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

5

5

Filing date: 11 Jun 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31791

8-K

Filing date: 15 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-31791

10-Q

Filing date: 15 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-31791

8-K

Filing date: 12 May 2025
Reporting date: 12 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-31791

8-K

Filing date: 31 Mar 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-31791

10-K

Filing date: 31 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 05 Mar 2025
Reporting date: 03 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31791

8-K

Filing date: 05 Mar 2025
Reporting date: 05 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-31791

FORM 8-K

Filing date: 18 Feb 2025
Reporting date: 18 Feb 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 30 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31791

8-K

Filing date: 28 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Jan 2025
Reporting date: 23 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .